Harmonet

Harmonet is a combined oral contraceptive tablet containing ethinylestradiol and gestodene. It is supplied in tablet form, marketed in the EU, and prescribed for hormonal contraception. The product provides a regulated dose of estrogen and progestogen to prevent pregnancy. Each tablet is intended for daily oral intake as part of a 21‑day active regimen followed by a hormone‑free interval. It is available only by prescription.

Harmonet is indicated for the prevention of pregnancy in women of reproductive age who choose an oral hormonal method.

- Primary use as a combined oral contraceptive to inhibit ovulation. - Provides cycle control and reduces menstrual flow. - May be used to manage moderate acne related to androgen excess. - Can be prescribed for treatment of dysmenorrhea associated with ovulatory cycles.

Like other combined oral contraceptives, Harmonet may cause a range of side effects, most of which are mild and transient.

Common: - Nausea or mild stomach upset. - Headache or migraine. - Breast tenderness. - Spotting or breakthrough bleeding.

Serious: - Deep vein thrombosis or pulmonary embolism. - Stroke or myocardial infarction. - Severe hypertension. - Liver disorders such as cholestatic jaundice.

Before starting Harmonet, certain health considerations should be evaluated to ensure safe use.

- History of blood clots, stroke, or heart disease. - Smoking, especially in women over 35 years of age. - Uncontrolled hypertension or diabetes. - Liver disease or severe gallbladder disease. - Migraine with aura. - Pregnancy or suspected pregnancy (contraindicated).

Harmonet can interact with other medicines, affecting its efficacy or increasing risk of adverse events.

Avoid: - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin). - Rifampin and other potent antibiotics (e.g., griseofulvin). - St. John’s wort herbal supplement.

Use with caution: - Antifungal agents such as ketoconazole. - Certain HIV protease inhibitors. - Selective serotonin reuptake inhibitors (SSRIs).